Geneva, Switzerland and Copenhagen, Denmark; November 1, 2005 – Serono (virt-x: SEO and NYSE: SRA) and Genmab A/S (CSE: GEN) announced today that an abstract has been selected for poster presentation at the 2005 Annual Meeting of the American Society of Hematology in Atlanta, Georgia. It is additional data from the HuMax-CD4 Phase II study in non-cutaneous T-cell lymphoma.

Francesco d’Amore will present the data from HuMax-CD4, PTCL on December 12, 2005 from 10:30 a.m. local time (hall B4, poster board no. 605).

“We are proud to be represented at this year’s ASH conference,” said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab.